Metastatic Breast Cancer (MBC) is breast cancer that has spread beyond breast tissue and the surrounding lymph nodes to form tumors in other parts of the body such as bones, brain, liver, and lungs. If you have been diagnosed with early stage breast cancer, it’s understandable if you don’t want to hear anything about MBC.  It is also understandable if all your focus is on wanting to get through your treatments and adjusting to the shock of your cancer diagnosis.  The most recent update from Cancer.net.  This year, an estimated 290,560 people (287,850 women and 2,710 men) in the United States will be diagnosed with invasive breast cancer. Breast cancer is the most common cancer in women in the United States, excluding skin cancer. Worldwide, female breast cancer has now surpassed lung cancer as the most commonly diagnosed cancer. It is now estimated that breast cancer is the second most common cause of death from cancer in women in the United States. It was reported over 5 years ago that more than 155,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage 1-3. 

You may feel a range of emotions and struggle to stay positive and hopeful that cancer will not come back.  You may struggle to guide yourself through the medical system, feeling scared and alone, fearing what might happen in the future.

The thing is, sometimes our fear can come to life when we don’t have all the information, we need to be vigilant and fearless advocates for our health. To benefit from advancements in research, testing and treatment, it is critical for all those touched by breast cancer to learn about the entire continuum of stages and possibilities, including MBC. Without access to correct information and timely treatments or clinical trials, your best life could be interrupted.

Metastatic breast cancer is the reality for far too many women across the world, many of these diagnosis’s can be prevented by early detection and treatments. Our mission is to one day see MBC as not a terminal disease but one that can be treated with a 100% success rate.